Impilo is the pioneer of healthcare transformation. It has completed the $11.5 million Series A round spearheaded by Construct Capital and joined by GC 1 Capital, One Way Ventures, 2048 Ventures, and other strategic angel investors.
These huge cash inflows will assist Impilo in achieving its transformative vision of removing the hurdles associated with accessing home care services.
Bringing the Doctor to Your Home
The company’s platform combines cutting-edge logistics, patient services, and data enablers that enable healthcare providers to deliver high-quality patient care from home.
Impilo consists of a number of connected devices, diagnostics, and medical supplies, and the service becomes a fully white-labelled solution that delivers the clinic right to the patient’s doorstep.
CEO’s Vision for the Future
The financing attracted pleasing remarks from Josh Stein, Impilo CEO, who said “This funding is a game changer to us.” It will enable us to generate higher growth rates, enter new geographies, and maintain developing solutions for enhancing access to health care.”
The investment is designed to improve Impilo’s technological platform and increase access to markets in the provider and payer spaces.
Support from Key Investors
Alex Iskold, General Partner at 2048 Ventures, expressed his further excitement as Impilo is working on at-home patient monitoring and is glad to be on board. Other panelists, such as Dayna Grayson of Construct Capital, also agreed with this notion of disruption. It is the company that has effectively provided at-home care in the future.
This funding will enable Impilo to transform healthcare delivery and bring quality healthcare to millions of patients across the country.
